West Visayas State University

COLLEGE OF NURSING
La Paz, Iloilo City

DRUG STUDY
Name: Attending Physician:
Age: Ward/Bed Number: Impression/Diagnosis:
Name of Drug Dosage, Mechanism of Indication Adverse Special Nursing
Route, Action Reactions Precautions Responsibilities
Frequency,
Timing
Generic: Dosage: Inhibits cell wall -UTI; lower - Pseudomembra - Dont mix or - Before giving, ask
respiratory tract, co administer patient if hes
ceftriaxone synthesis, nous colitis
gynecologic, ceftriaxone allergic to
- Anaphylaxis
sodium promoting osmotic bone or joint,
- Leukopenia with calcium penicillins or
intra-abdominal,
Route: instability, usually - Thrombocytosis containing IV cephalosporins.
skin, or skin
I.V. bactericidal. structure solutions, - If large doses are
infection; including given, therapy is
Brand: prolonged.
septicemia. parenteral
Rocephin Frequency: -Uncomplicated nutrition. This - Monitor for signs
gonococcal vulvo includes the and symptoms of
vaginitis superinfection.
Classification use of
-Meningitis - Monitor PT in
-Perioperative different
Functional: Timing: Side Effects infusion lines
patients with
prevention
impaired vitamin
Antibiotic -Acute bacterial - Diarrhea at different
otitis media K or low vitamin K
- Pain sites.
-Pelvic inflammatory - Use stores.
- Tenderness at
Chemical: disease - Tell patient to
cautiously in
-Lyme disease injection site report adverse
Third generation breast-
reactions
Contraindications feeding
cephalosporin promptly.
women and in
- Instruct patient to
patients with
Contraindicated in report discomfort
patients history of
at IV insertion
hypersensitive to colitis and
site.
drug or other renal - Tell patients to
cephalosporins. insufficiency. notify prescriber
 about loose stools
or diarrhea.

Students Name: BSN 3-B Group 2

West Visayas State University

DRUG STUDY
Name: Attending Physician:
Age: Ward/Bed Number: SLRW Impression/Diagnosis:
Name of Drug Dosage, Mechanism of Indication Adverse Special Nursing
Route, Action Reactions Precautions Responsibilities
Frequency,
Timing
Generic: Dosage: Inhibits bacterial - Corneal ulcers - White - Stope drug at - Tell patient to
caused by first sign of clean eye area of
ciprofloxacin DNA gyrase, an crystalline
Pseudomonas hypersensitivity, excessive
hydrochloride enzyme needed for aeruginosa, precipitate in discharge before
such as rash,
Staphylococcus instilling.
Route: bacterial replication. superficial and notify
aureus, S. - Teach patient how
portion of prescriber. to instill drops or
epidermis, Serious apply ointment.
Brand: Streptococcus corneal defect
hypersensitivity Advise him to
Ciloxan Frequency: pneumoniae, and in patients wash hands
reactions,
possibly Serratia before and after
with corneal including
marcescens and using drug and
Streptococcus anaphylaxis,
ulcers, not to touch tip of
viridans. may occur in dropper to eye or
Timing: conjunctiva patients
- Bacterial surrounding
Classification - Conjunctival
conjunctivitis receiving tissues.
caused by hypereremia systemic drug. - Instruct patient to
Functional:
Haemophilus - Allergic - Use cautiously in apply light finger
Antibiotic influenza, S. breastfeeding pressure on
reactions
aureus, S. women. lacrimal sac for 1
- Prolonged use minute after drops
epidermidis, and
Chemical:
possibly S. Side Effects may result in
are instilled.
- Advise patient
Fluoroquinolone pneumoniae. overgrowth of of
- Itching that drug may
- Local burning nonsuceptible cause temporary
Contraindication organisms, blurring of vision
or discomfort
s including fungi. or stinging after
- Bad or bitter
- Contraindicated in administration. If
taste in these symptoms
patients
become
mouth.
hypersensitive to pronounced or
worsen, contact
drugs or other
prescriber.
fluoroquinolones - Tell patient to
avoid wearing
contacts while
treating bacterial
conjunctivitis.
- Tell patient not to
share drug,
washcloths, or
towels with family
members and to
notify prescriber if
 anyone develops
same signs or
symptoms.
- Institute
appropriate
therapy if
superinfection
occurs.
- Stress importance
of compliance
with
recommended
therapy.

Students Name: BSN 3-B Group 2